Current estimates of fungal disease incidence and mortality are imprecise. Population at risk
denominators were used to estimate annual incidence for 2019–21. Extensive literature …

Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …

Reports are increasing on the emergence of COVID‐19–associated mucormycosis (CAM)
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …

In October, 2022, WHO published the first fungal priority pathogen list, which categorised 19
fungal entities into three priority groups (critical, high, and medium), for prioritisation of …

Background Mucormycosis, a rare fungal infection, has shown an increase in the number of
reported cases during the COVID-19 pandemic. Objectives To provide a comprehensive …

Coronavirus Disease 2019 (COVID-19), during the second wave in early 2021, has caused
devastating chaos in India. As daily infection rates rise alarmingly, the number of severe …

Mucormycosis (MCR) is an emerging and frequently lethal fungal infection caused by the
Mucorales family, with Rhizopus, Mucor, and Lichtheimia, accounting for> 90% of all cases …

Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for develo** invasive fungal infections. Influenza virus is one of the most …

Mucormycosis (previously called zygomycosis) is a serious but rare fungal infection caused
by a group of fungi belonging to the order Mucorales. These molds exist throughout the …